Profund Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-6,434
Closed -$299K – 1100
2023
Q2
$299K Buy
+6,434
New +$222K 0.02% 724

Profund Advisors's DICE Position: Q3 2023 in Review

Profund Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 6,434 shares — an estimated $299K sold.

Profund Advisors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $299K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Profund Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Profund Advisors sold 6,434 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $299K.
  • Profund Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Profund Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $299K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Profund Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.